Fluclotizolam Stats & Data

Potency varies by batch; start with no more than 0.1–0.25 mg and wait 2+ hours before considering any redose. Sub-milligram accuracy is essential—use volumetric dosing (e.g., 1 mg in 10 mL 50:50 ethanol:water or PG/ethanol) measured with a marked oral syringe; do not rely on drop counts due to large variability. Most benzodiazepines are poorly water-soluble and perform unpredictably intranasally; oral or sublingual routes are safer and more consistent. New benzodiazepines are frequently mis-sold or adulterated; counterfeit 'benzo' tablets and liquids have been found to contain bromazolam, stimulants, and even nitazene opioids—use an accredited drug checking service where available. Combining with opioids or other depressants is the primary cause of fatal outcomes; avoid co-use, and ensure naloxone and oxygen access if opioids are present. Short-acting, high-potency benzos increase blackout and 'delusions of sobriety'; set a hard cap (≤0.5 mg per 12 h) and avoid daily use. Expect rebound insomnia/anxiety as effects wear off; spacing uses by weeks reduces tolerance and withdrawal risk. Standard immunoassay urine tests target oxazepam-like metabolites and may miss some designer benzos; specialized confirmatory testing is needed. Avoid driving or hazardous tasks for at least 8–12 h after the last dose, longer if drowsy.